Aims: Very modest changes in mRNA stability can aff ect critical points in cellular energy pathways. The aim of this study was to investigate the impact of energy abundant substrates on peroxisome proliferator-activated receptors (PPARs) and PPAR-γ coactivators (PGCs) mRNA's steady-state levels.
INTRODUCTION
Living organisms must continuously adapt their energy metabolism to a discontinuous supply of nutrients. In mammals, the relationship of carbohydrate metabolism to fat utilization is complex. The liver plays a key role in the maintenance of systemic energetic homeostasis. During a medium-to long-term fast, gluconeogenesis is turned on to maintain appropriate blood glucose levels. In addition, adipose tissue acts with the liver to ensure glucose homeostasis during the postabsorptive period. Fatty acid oxidation is activated, providing energy for tissues and, in the liver, for the gluconeogenic process. Collaterally, ketone bodies are exported from the liver providing an alternative fuel source to glucose. According to the conventional view, systemic transition from the fed to fasted state is entirely orchestrated by hormones. Upon starvation, when the insulin:glucagon ratio is low, gluconeogenesis and lipolysis are induced by a synergistic action of glucagon and glucocorticoids, while lipogenesis is inhibited. The hormones mainly elicit these changes by modulating transcription of genes that are involved in glucose and fatty acid metabolism 1 . Over the recent years, it has become apparent that the control of transcription by nutrients and their cellular metabolites provides another mechanism, additional to hormones, that allows cells to respond to changes in their nutritional environment. More specifi cally, amino acids, glucose, and non-esterifi ed, or free fatty acids (FFA) have been all recognized as universal cellular regulators 1 . For instance, available data suggest that mechanisms of FFA-induced changes involve a number of DNA-binding transcription factors executing pleiotropic metabolic actions. Of these, peroxisome proliferator-activated receptors (PPAR)-α, -β, and -γ have emerged as a molecular rationale for the link between fatty acid and/or glucose availability and the gene expression control. 2 The primary PPAR subtype in the liver is PPAR-α. PPAR-α controls many aspects of energy metabolism, particularly those involved in liver glucose synthesis, lipid oxidation and glucose sparing processes that are activated in the postabsorptive state. PPAR-α-null mice suff er from marked hy-poglycaemia upon fasting and are steatotic owing to a decreased FFA oxidation capacity. Pharmacological agonists of PPAR-α are known as antihyperlipidemic agents improving the impaired insulin sensitivity 3, 4, 5 . Moreover, recent studies have revealed the presence of accessory, ligand-independent transcriptional coactivator molecules in cells that are essential for the activation of nuclear receptors and transcription factors. In particular, a family of coactivators closely related to PPARs and involving two PPAR-γ-coactivators (PGC-1α and -1β) together with PGC-1-related coactivator (PRC) have been discovered and shown to play prominent roles in both physiological and pathological processes 6, 7 . Under fed conditions, PGC-1α is suppressed by insulin and its abundance in liver is low. However, it has been found to dramatically increase in fasted animals 8, 9 . PGC-1α-null mice exhibit impaired gluconeogenesis, fasting hypoglycaemia, and liver steatosis upon fasting [10] [11] [12] , whereas PGC-1α overexpression in the liver is associated with elevated hepatic glucose production 9 . These data are of clinical importance since impaired expression of PPARs and/or PGCs probably contributes to hyperglycaemia in diabetes mellitus and/or liver steatosis in obesity.
Elucidation of the complex interplay between hormones, substrates, transcriptional factors, and genes is critical for our understanding of both benefi cial and harmful eff ects of nutrition on human health. Energy abundant substrates, such as carbohydrates and fats, have been widely acknowledged to have diff erent eff ects, to selectively infl uence the responses of specifi c hepatic genes, depending upon the particular nutritional and hormonal context 1 . Despite much recent progress, the function of PPAR/PGC machinery in several basic aspects of the hepatic fasting response remains unexplored. Little is known about direct action of the energetic nutrients on the expression of genes in hepatocytes upon starvation. In particular, the control of steady-state levels of mRNA, representing the outcome of mutually competing processes of mRNA synthesis and degradation, is now increasingly appreciated as a powerful mechanism for regulating gene activity in virtually all cells in the human body 13 . In this regard, very modest changes in mRNA stability and decay have been described to impact critical points in cellular pathways important for energy metabolism that have been correlated with serious metabolic disturbances in human beings 6, [14] [15] [16] . This quantitative RT-PCR study was conducted to investigate, in the absence of hormones, the eff ects of glucose and oleic acid on the cytoplasmic mRNA content of several molecules functionally clustered round PPAR transcription factors in human hepatoma-derived HepG2 cells. First, we focused on PPAR-α, -γ1, and -γ2 mRNA levels. Second, assuming that expression of the PPAR coactivators may also be aff ected, we included PGC-1α and -1β mRNAs in our study. Third, we analyzed changes in mRNA levels of the studied molecules using transcriptional and translational inhibitors to get insight into the mechanisms behind them.
MATERIALS AND METHODS

Materials
Eagle's minimum essential medium (EMEM), penicillin, streptomycin, sodium pyruvate, L-glutamin, trypsin, bovine serum albumin (BSA), fatty acid-free BSA, D-glucose, cycloheximid, actinomycin-D, and oleic acid were purchased from Sigma-Aldrich (St. Louis, MO). Glucosefree Dulbecco's modifi ed Eagle's medium (DMEM) and fetal bovine serum (FBS) was obtained from Gibco (Grand Island, NY).
Preparation of the oleic acid-BSA complex
Fatty acid-free BSA was dissolved in EMEM medium supplemented with 1% FBS and oleic acid was added to this solution to achieve 2:1 oleic acid-BSA ratios. The mixture was vortexed and sonicated until optically clear and used immediately.
Cell culture
HepG2 cells (ATCC, Rockville, MD, USA) were grown to about 80% confl uence in Eagle's minimum essential medium (EMEM) supplemented with 10% fetal bovine serum (FBS), 1 mmol/l sodium pyruvate, 2 mmol/l L-glutamine, and 50 IU/ml penicillin/streptomycin in a humidifi ed 5% CO 2 /95% air atmosphere at 37 °C. During this period the medium was replaced by fresh medium (containing all supplements) every 48 h. The medium was then switched to Dulbecco's modifi ed Eagle's medium (DMEM) lacking glucose supplemented with 1% FBS (w/ v). BSA was adjusted in all target samples and controls to a fi nal concentration of 1% (w/v). Based on our preliminary results the experimental treatment was carried out for 0.5 or 4 h periods with D-glucose at 0 mmol/l or 5 mmol/l concentrations without or with the above oleic acid-BSA complex added to a fi nal concentration of 0.3 mmol/l oleic acid. Three independent experiments were performed for each time interval and glucose and/or oleic acid concentration used and all measurements were performed in duplicate.
The eff ect of cycloheximide on the accumulation of mRNA
To examine the role of de novo protein synthesis under the diff erent experimental settings, HepG2 cells grown to about 80% confl uence were further incubated under zero or normal glucose without or with 0.3 mmol/l oleic acid and without or with 1.4 μg/ml translational inhibitor cycloheximide. After 4 h, total RNA was isolated from the cells and mRNA levels were measured by real-time RT-PCR, as described below.
The eff ect of actinomycin D on the stability of mRNA
For mRNA stability studies, HepG2 cells grown to about 80% subconfl uence were further incubated under zero or normal glucose without or with 0.3 mmol/l oleic acid for 3 h. After 3 h, transcriptional inhibitor actinomycin D (4 μg/ml) was added to one set of target samples to stop mRNA transcription for another 1 h. Another set of mRNA levels of peroxisome proliferator-activated receptors and their coactivators are aff ected by glucose deprivation and oleate in human hepatoma HepG2 cells target samples was treated with the combination of both actinomycin D (4μg/ml) and cycloheximide (1.4 μg/ml). Control cells were maintained untreated with the inhibitors for the same 1 h time interval. After 1 h, total RNA was isolated from the cells and mRNA levels were measured by real-time RT-PCR, as described below.
Quantitative real-time RT-PCR for mRNA analysis
Quantitative real-time PCR was performed to measure the mRNA levels of the studied genes using the rapid thermal LightCycler system (Roche Diagnostics, Mannheim, Germany). Total RNA was extracted from 10 6 cells using the High Pure RNA Isolation kit, and mRNA was reversetranscribed using the Transcriptor First Strand cDNA Synthesis kit (both kits from Roche). Primers (Tab. 1) were designed using the NCBI nucleotide database and LightCycler Probe Design software (HPRT primers) or adopted according to the data of others and were synthesized by Metabion International (Martinsried, Germany). Twenty microliters of a reaction mixture consisting of FastStart DNA MasterPLUS SYBR Green I (Roche), the forward and reverse primers (0.5 μmol/l each), and an aliquot of the reverse-transcribed samples (2 μl) were contained in a LightCycler glass capillary. Negative controls were tested in parallel. The quality of the PCR products detected with SYBR green was routinely confi rmed by melting curve analysis and, in initial experiments, by agarose gel electrophoresis using ChemiGenius System computerized densitometry (Syngene, Cambridge, UK).
Relative mRNA quantifi cation and statistical evaluation
A normalization factor derived from multiple reference genes (Tab. 1) measured in the same RNA sample was used to compute the relative expression ratio 22 . Three separate experiments were performed, and each determination was executed in duplicate. The PCR data characterizing the relative mRNA expression levels in target samples were compared to the corresponding values for controls using t-test and, within groups, ANOVA and LSD post hoc test. The results presented in the text and the fi gures correspond to mean ± SD values. The statistical signifi cance was set at p < 0.05.
RESULTS
Eff ects of glucose deprivation and oleate on mRNA levels.
Using quantitative real-time RT-PCR we fi rst studied the eff ects of 0.5 h and 4 h incubations with zero or normal (5 mmol/l) concentrations of glucose and/or oleic acid (0.3 mmol/l) on mRNA expression of several molecular species functionally allied to PPAR transcriptional factors in HepG2 cells. In fi gure 1, relative mRNA levels of PPAR-α, -γ1, -γ2, and PGC-1α and -1β determined in duplicate assays from three independent experiments were compared to the control mRNA levels of the same molecules when cells were maintained under normal glucose without oleate (the basal state) during the early incubation period. At the end of this period, there was a modest but signifi cant elevation in PGC-1α mRNA level in HepG2 cells maintained in the absence of both glucose and oleate (123 % of the control level; p < 0.05) (Fig. 1) . Furthermore, significant increase in PGC-1β mRNA levels could be seen during the early incubation period brought about by 0.3 mmol/l oleate (134 % and 160 % of control levels for zero glucose plus oleate and normal glucose plus oleate, respectively; p < 0.05 for each) (Fig. 1) . All together these fi ndings indicated that during the early incubation period, PGC-1α mRNA abundance was signifi cantly upregulated in the absence of glucose, while PGC-1β mRNA content was signifi cantly enhanced in the cells by oleate, irrespective of glucose concentrations. No signifi cant change in PPAR mRNAs was detected in this early period.
We next measured the relative mRNA levels in target samples during the prolonged incubation period (4 h). From fi gure 2 it is obvious that at the end of this incubation, PPAR-γ1 and PGC-1α mRNA levels were signifi cantly elevated in glucose-oleate-starved samples compared with the control (basal) state (142 % and 163 % of control levels, respectively; p < 0.05 for each). This zero glucoseinduced elevation in PPAR-γ1 and PGC-1α mRNAs was also signifi cant upon the administration of 0.3 mmol/l oleate (132 % and 131 % of control levels, respectively; p < 0.05 for each) (Fig. 2) . In contrast, oleate significantly suppressed PPAR-α and PGC-1β mRNA levels in Table 1 . Primers used for quantitative real-time PCR analyses.
Forward primer (5'-3')
Reverse primer (5'-3') Ref. Target  PPARγ1 AAAGAAGCCGACACTAAACC  CTTCCATTACGGAGAGATCC  17  PPARγ2 GCGATTCCTTCACTGATAC  CTTCCATTACGGAGAGATCC  17  PPARα  ACTTATCCTGTGGTCCCCGG  CCGACAGAAAGGCACTTGTGA  18  PGC1α  TGTGCAACTCTCTGGAACTG  TGAGGACTTGCTGAGTGGTG  19  PGC1β  GCTCTCCTCCTTCTTCCTCA  ATAGAGCGTCTCCACCATCC  19  Reference  CynA  GCATACGGGTCCTGGCATCTTGTCC ATGGTGATCTTCTTGCTGGTCTTGC  20  GAPDH ACCACAGTCCATGCCATCAC  TCCACCACCATGTTGCTGTA  21  HPRT  GGACTGAACGTCTTGC Mean relative mRNA expression levels of target genes were expressed as a fold-increase compared to the control. Three independent experiments were performed for each treatment and each determination was executed in duplicate. * denotes signifi cant diff erence (p < 0.05) for within group variance analyzed by ANOVA with post hoc signifi cance test. mRNA levels of peroxisome proliferator-activated receptors and their coactivators are aff ected by glucose deprivation and oleate in human hepatoma HepG2 cells glucose-deprived cells (58 % and 49 % of control levels, respectively; p < 0.05 for each) (Fig. 2) . Finally, PPAR-γ2 mRNA levels varied only insignifi cantly at the end of the 4 h period (Fig. 2) .
The dependence of mRNA content on de novo protein synthesis. To get further insight into the molecular mechanisms of the above eff ects, we asked whether these effects were dependent on de novo synthesis of proteins. To investigate this, the cells were incubated in the presence or the absence (control) of translational inhibitor cycloheximide (1.4 μg/ml, 4 h). From RT-PCR analyses of duplicate assays from three independent experiments in fi gure 3 it is apparent that in all experimental settings, PPAR-γ2 mRNA level was signifi cantly superinduced in cells by administration of cycloheximide, both in the absence and the presence of oleate. More specifi cally, upon cycloheximide treatment, PPAR-γ2 mRNA was elevated to about the same extent in zero and normal glucose settings (353 % and 388 % of control levels, respectively; p < 0.05 for each) (Fig. 3) . The presence of oleate did not preclude these elevations (303 % and 356 % of control levels for zero glucose plus oleate and normal glucose plus oleate, respectively; p < 0.05 for each) (Fig. 3) . Also signifi cantly superinduced by cycloheximide, albeit to a lesser extent, were the PPAR-γ1 mRNA levels in cells maintained in normal glucose settings, both in the absence and the presence of oleate (124 % and 125 % of control levels, respectively; p < 0.05) (Fig. 3) . In contrast, cycloheximide signifi cantly suppressed PPAR-α mRNA content in zero glucose and normal glucose-oleate samples (43 % and 54 % of control levels, respectively; p < 0.05). The decrease in PPAR-α mRNA level caused by cycloheximide in zero glucose plus oleate and normal glucose samples did not reach statistical signifi cance (77 % and 71 % of control levels, respectively) (Fig. 3) . Furthermore, PGC-1α mRNA was consistently reduced upon cycloheximide administration in all experimental settings (42 %, 44 %, 47 %, and 51 % of control levels for zero glucose, zero glucose plus oleate, normal glucose, and normal glucose plus oleate, respectively; p < 0.05) (Fig. 3) . Also PGC-1β mRNA levels were reduced by the presence of cycloheximide in all experimental batches (73 %, 77 %, 57 %, and 76 % of control levels for zero glucose, zero glucose plus oleate, normal glucose, and normal glucose plus oleate, respectively; p < 0.05) (Fig. ) . These fi ndings indicated that with the exception for PPAR-γ1 mRNA in glucose-deprived cells, both PPAR-γ mRNAs were superinduced in the absence of de novo protein synthesis, whereas PPAR-α and PGC-1α and-1β mRNAs required de novo protein synthesis for their integrity.
Actinomycin D eff ects. Considering that the amount of mRNAs can be regulated by both transcriptional and posttranscriptional mechanisms, we asked whether the turnover of the studied mRNAs was aff ected in the cells. In preliminary experiments, we had estimated that decay rates for most studied mRNAs were higher in the fi rst 2.0-2.5 hours following administration of actinomycin D, which was added to block new transcription, than in the later period (data not shown). Then, to investigate mRNA turnover, the cells were incubated for 3 h to induce changes in mRNA levels (control, 100 %) and then the rate of decline of mature mRNAs was estimated upon 1 h treatment of the cells with actinomycin D (4 μg/ml). Concurrently, actinomycin D was used together with cycloheximide to reveal the combined eff ects of these inhibitors. The results of duplicate assays from three independent experiments were plotted in fi gure 4. First, from the PPAR-α mRNA decay data it can be seen that in the presence of actinomycin D alone, PPAR-α mRNA decreased faster in cells incubated under normal glucose than in glucose-deprived cells (56 % of the control level for normal glucose vs. 99 % of the control level for zero glucose). The diff erence achieved signifi cance when the incubation media were supplemented with oleate (47 % of the control level for normal glucose-oleate vs. 93 % of the control level for zero glucose plus oleate; p < 0.05) (Fig. 4) . This finding indicates that glucose shortage stabilized PPAR-α mRNA in comparison to normal glucose concentration. Moreover, when actinomycin D was used together with cycloheximide, we observed mild to strong upregulation of PPAR-α mRNA content in all cell batches (129 %, 207 %, 180 %, and 149 % of control levels for zero glucose-actinomycin D-cycloheximide, zero glucose-oleate-actinomycin D-cycloheximide, normal glucose-actinomycin D-cycloheximide, and normal glucose-oleate-actinomycin D-cycloheximide, respectively). In all but the fi rst of these, this upregulation achieved statistical signifi cance when the samples were compared with their counterparts incubated without cycloheximide (p < 0.05) (Fig. 4) . Second, following actinomycin D treatment of glucose-deprived cells, PGC-1α mRNA amount was signifi cantly lower in cells supplemented with oleate (60 % of the control level) than in those incubated in its absence (77 % of the control level), suggesting that PGC-1α mRNA was destabilized in glucose-deprived, oleate-treated cells (p < 0.05) (Fig. 4) . Finally, we found that upon 1 h actinomycin D or actinomycin D-cycloheximide administration, basal PPAR-γ1, -γ2, and PGC-1β mRNA levels were about 80±18 %, 85±32 %, and 70±16 % and were not signifi cantly aff ected by the presence or absence of glucose and/or oleate. Notably, in contrast to the above fi ndings, no signifi cant PPAR-γ mRNA superinduction was observed when actinomycin D was combined with cycloheximide during this 1 h incubation period (data not shown).
DISCUSSION
Steady state levels of mRNA are the outcome of mutually antagonistic processes of mRNA synthesis and degradation. It is now increasingly appreciated that the control of these processes functions as a powerful mechanism for regulating gene activity. In this article, we provide evidence for the regulation of mRNA expression of several members of the PPAR signaling machinery by abundant dietary and plasma substrates, glucose and oleate. Notably, mRNA expression of PPAR-α, -γ1, and -γ2 and PPAR-γ , and real-time RT-PCR was performed to quantify mRNA levels. Control mRNA levels without cycloheximide were defi ned as 100 %, and mRNA levels in samples were calculated as percentage of this value. Three independent experiments were performed for each treatment and each determination was executed in duplicate. # denotes signifi cant diff erence (p < 0.05) when target and control cells were compared using t-test. * denotes signifi cant diff erence (p < 0.05) for within group variance analyzed by ANOVA with post hoc signifi cance test.
coactivators PGC-1α and -1β has been aff ected in HepG2 cells by exogenous substrates in the absence of variation in the ambient hormonal milieu of the cells 1, 8, 9 . PPAR intracellular transcriptional factors are situated at the core of the cellular control of energy status. Recently it has been shown that in addition to its important role in fatty acid metabolism, PPAR-α can upregulate the genes involved in hepatic gluconeogenesis. Accordingly, PPAR-α has been ascribed a pivotal role in the adaptive response to fasting [23] [24] [25] [26] . In HepG2 cells incubated in the presence of 10% FBS and normal glucose, . In our study, hormonal stimulation of cells that normally regulate fed-to fasted-state transition was avoided. We detected signifi cant decline in PPAR-α mRNA level upon prolonged (4 h) incubation of HepG2 cells in medium lacking glucose but containing 0.3 mmol/l oleate. This eff ect was absent in cells maintained under normal glucose (Fig. 2) . The diff erences between the model used by Fujiwara et al. (2003) (ref. 27 ) and ours are likely to explain these confl icting fi ndings. We have further demonstrated that PPAR-α mRNA stability is dependent on de novo protein synthesis and elevated in glucose-deprived, actinomycin D-treated cells. At the same time, we have shown that PPAR-α mRNA is superinduced by cycloheximide in cells when transcription is blocked. More experiments are clearly needed to resolve this puzzle. However, it is appropriate to mention that rather enigmatic mRNA superinduction in the absence of transcription is not exceptional. For instance, it has been also described in a study focused on PGC-1-related coactivator (PRC) variations during cell cycling 28 . In addition to PPAR-α, both PPAR-γ1 and -γ2 proteins are detectable in the liver, despite relatively low mRNA levels of these proteins in cells of hepatic origin 29 . According to the present study, PPAR-γ1 mRNA signifi cantly increased in HepG2 cells maintained for four hours in a medium lacking glucose, while PPAR-γ2 mRNA did not. The PPAR-γ1 mRNA elevation is also apparent in glucose-deprived cells in the presence of oleate, whereas no signifi cant eff ect of oleate on PPAR-γ2 mRNA is observable (Fig. 2) . In comparison, in the above mentioned study, Fujiwara et al. (2003) detected stimulation of PPAR-γ mRNA expression (isoform not specifi ed) in HepG2 cells following 24 h oleate treatment 27 . In a recent study by Edvardsson et al. (2006) isolated mouse hepatocytes maintained with 0.5 mmol/l oleate (in the presence of 0.75% albumin and 11 mmol/l glucose) were markedly upregulated PPAR-γ2 mRNA amount, whereas that of PPAR-γ1 mRNA remained unchanged 30 . Species and model variations are likely to be taken into account to un-243 mRNA levels of peroxisome proliferator-activated receptors and their coactivators are aff ected by glucose deprivation and oleate in human hepatoma HepG2 cells derstand the cause of these discrepancies. Administration of translational inhibitor cycloheximide in the present work revealed strong PPAR-γ2 mRNA superinduction in both glucose-fed and glucose-deprived cells, whereas superinduction of PPAR-γ1 was modest and only detectable in the presence of glucose, indicating that PPAR-γ1 and -γ2 mRNA transcripts are diff erently regulated in normal glucose and zero-glucose settings (Fig. 3) . This further stresses that the precise roles of the control of the expression of these two isoforms in mediating PPAR-γ functions in cells remain to be defi ned.
PGC-1α and -1β have been implicated by previous authors as the key ligand-independent coactivators of PPARs as well as many other nuclear receptors. Studies on PGC-1 suggest that they are tightly regulated in a tissue-specifi c manner. Relevantly, both these isoforms have been found to be markedly elevated in fasted liver. PGC-1α controls mitochondrial energy metabolism and stimulates gluconeogenesis 6, 7, 31 . The present increase in PGC-1α mRNA in HepG2 cells incubated in the absence of glucose, both without and with oleate, is fully consonant with both, the pro-oxidative and gluconeogenic PGC-1α functions of PGC-1α. Notably, PGC-1α mRNA is the only one of the explored mRNAs that was signifi cantly upregulated in both the early (0.5 h) and prolonged (4 h) incubation periods. Moreover, this increase was induced in HepG2 cells by glucose deprivation per se, i.e. in the absence of exogenous stimulation of the cells by glucorticoids or hormones that physiologically activate PGC-1α via the cAMP pathway. Presumably, the persistent abundance of PGC-1α mRNA in cells lacking glucose and treated with oleate (Fig. 2) may be related to combined PGC-1α stimulatory gluconeogenic and β-oxidation eff ects 32 . PGC-1α has been also reported to interact with PPAR-α to maintain constitutive fatty acid oxidation 6, 7, 31 . However, in neither the early nor prolonged time periods did the signifi cant changes in PGC-1α mRNA levels, observed by us, correlated with those of PPAR-α mRNA. This fi nding supports that although PGC-1α and PPAR-α may closely cooperate in regulating oxidative and gluconeogenic processes, the link between them is not simply linear. For instance, it is well known that stimulation of PPAR-α by its pharmacological agonists can improve impaired insulin sensitivity, whereas PGC-1α overexpression in the liver contributes to hyperglycaemia associated with insulin resistance and diabetes mellitus [3] [4] [5] 9 . . Concurrently, 4 μg/ml actinomycin D together with 1.4 μg/ml cycloheximide (AC) was used to reveal combined eff ects of these inhibitors. At the end of incubation, the cells were harvested, and mRNAs were analyzed by real-time RT-PCR. Control mRNA levels at the end of the 3 h pre-incubation were defi ned as 100%, and mRNA levels in samples were calculated as percentage of this value. Three independent experiments were performed for each treatment and each determination was executed in duplicate. # denotes signifi cant diff erence (p < 0.05) when target and control cells were compared using t-test. * denotes signifi cant diff erence (p < 0.05) for within group variance analyzed by ANOVA with post hoc signifi cance test.
We have demonstrated that PGC-1β mRNA content is signifi cantly enhanced in HepG2 cells by oleate, irrespective of glucose concentrations, in the early (0.5 h) incubation period. However, in contrast to PGC-1α, this PGC-1β mRNA burst is only transient since it did not persist with the prolonged (4 h) incubation period. Moreover, oleate signifi cantly suppressed the PGC-1β mRNA level during the prolonged incubation in the absence of glucose. Supposedly, this relatively rapid drop in PGC-1β mRNA level is understandable since PGC-1β functions as an eff ective coactivator of the genes involved in lipogenesis and lipoprotein secretion, rather than an activator of gluconeogenic genes 6, 7 . However, more work is clearly needed to elucidate the molecular mechanisms behind the biological action of the two PGCs. Notably, the present study reveals the decline in PGC-1β mRNA levels after the 4 h administration of cycloheximide, implying that this mRNA may require de novo protein synthesis to supply it with one or more positive mRNA-stability regulator(s) for its integrity.
CONCLUSIONS
In conclusion, this paper provides evidence for the eff ects of glucose deprivation and/or oleate administered at near-physiological levels on mRNA content, in Hep G2 cells, of several regulatory components associated with the PPAR-dependent signalling machinery, known to play critical roles in a number of both physiological and pathological states. Signifi cantly, the changes in mRNA content were elicited by nutrient variations without alteration in the ambient hormonal milieu of the cells. Our fi ndings suggest that the transcriptional processes generating the investigated mRNAs to be interconnected with concurrent translational processes that can either destabilize, or stabilize mRNAs. Whether the changes in mRNA levels project into the activity of appropriate proteins remains to be explored. Our fi ndings open way for designing experiments to unravel the processes behind the new observations.
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